Nachrichten zur Johnson & Johnson Aktie

Hims & Hers adds Eli Lilly GLP-1 drugs, Johnson & Johnson setback

Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to discuss some of the top stories of the trading day,…

Warten auf das Zollpaket: Dow kaum verändert - Johnson & Johnson unter Druck

Einen Tag vor der Verkündung einschneidender Importzölle in den USA haben sich Investoren an der Wall Street merklich zurückgehalten. Der…

Why Johnson & Johnson Stock Is Sinking Today

Shares of Johnson & Johnson (NYSE: JNJ) are tumbling on Tuesday. The companys stock lost 6.3% as of 2:25 p.m.…

Can Johnson & Johnson (JNJ) Keep the Earnings Surprise Streak Alive?

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

This Recession-Proof Stock Soared Through the Dot-Com Bust, the Financial Crisis, and the 2022 Inflation Spike. Is It a No-Brainer Buy for the Trump Tariff Era?

President Donald Trump has barely been in office for two months, but his policies and proposals have already rocked the…

ROUNDUP/Erneut juristischer Dämpfer für J&J: Keine Lösung für Babypuder-Klagen

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) muss im Streit um angebliche Gesundheitsrisiken bestimmter Babypuder vor…

ROUNDUP/Erneut juristischer Dämpfer für J&J: Keine Lösung für Babypuder-Klagen

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) muss im Streit um angebliche…

ROUNDUP/Erneut juristischer Dämpfer für J&J: Keine Lösung für Babypuder-Klagen

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (JohnsonJohnson) (J&J) muss im Streit um angebliche Gesundheitsrisiken bestimmter Babypuder vor…

dpa-AFX-Überblick: UNTERNEHMEN vom 01.04.2025 - 15.15 Uhr

Juristische Watsche für J&J: Treuhandfonds für Babypuder-Klagen erneut abgelehnt NEW BRUNSWICK - Der US-Konzern Johnson & Johnson…

Juristische Watsche für J&J: Treuhandfonds für Babypuder-Klagen erneut abgelehnt

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) hat im Streit um angebliche Gesundheitsrisiken bestimmter Babypuder…

Juristische Watsche für J&J: Treuhandfonds für Babypuder-Klagen erneut abgelehnt

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) hat im Streit um…

Stocks making the biggest moves premarket: PVH, Johnson & Johnson, Newsmax, Shake Shack and more

These are the stocks posting the largest moves in premarket trading.…

Johnson & Johnson shares fall as US judge rejects $10B talc settlement plan

Johnson & Johnson (NYSE:JNJ) shares moved almost 5% lower after a US bankruptcy judge rejected its $10 billion settlement proposal…

J&J shares fall after judge rejects $10 billion talc settlement

Johnson & Johnson shares fell more than 3% on Tuesday after a U.S. bankruptcy judge rejected its $10 billion proposal…

2 Value Stocks Im Buying Right Now

Investing in this market isnt fun. Geopolitical tensions are escalating to levels not seen in decades, global trade relationships face…

U.S. judge rejects Johnson & Johnsons $10 billion baby powder settlement

A U.S. bankruptcy judge on Monday rejected J&Js $10 billion proposal to end tens of thousands of lawsuits.…

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Procter & Gamble, Johnson & Johnson Among 10 Companies To Announce Dividend Increases In First Half Of April

…

3 Relatively Safe Stocks to Buy Right Now

Investing in stocks comes with risks. Theres no way around that fact. However, some stocks can be less risky than…

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case By Reuters

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case…

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case

A federal judge ordered Janssen to pay $1.64 billion after a jury found it liable in a whistleblower lawsuit for…

Deutsche Bank belässt Astrazeneca auf Hold - Ziel 11000 Pence

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca auf "Hold" mit einem Kursziel von 11000 Pence…

Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts

The latest trading day saw Johnson & Johnson (JNJ) settling at $163.29, representing a -0.21% change from its previous close.…

Johnson & Johnson to invest more than $55bn in US over next four years

The commitment marks a 25% increase to the companys US investments in the past four years…

The Best Vanguard ETF to Invest $2,000 in Right Now

Theres a lot of uncertainty surrounding the economy and stock market right now. Between tariff news, trade tensions, and all…

List of companies pledging to invest billions in US since Donald Trump win

Trump has brought in some big investments in his two months in office, most recently Johnson & Johnson.…

Heres Why You Should Consider Investing in Johnson Controls Now

JCI gains from solid momentum across its segments, accretive acquisitions and shareholder-friendly policies.…

J&J touts $55B in planned US investments over 4 years, including 3 new manufacturing sites

Johnson & Johnson says it will s | Johnson & Johnson will invest $55 billion in the U.S. over the…

J&J boosts investments in U.S. to more than $55 billion amid looming tariff threats

Johnson & Johnson plans to spend over $55 billion to build four plants in the U.S., it said on Friday.…

J&J boosts investments in US to more than $55 billion amid looming tariff threats

Johnson & Johnson plans to spend over $55 billion to build four plants in the U.S., it said on Friday.…

Johnson & Johnson plans $55 billion in US investments over the next four years

Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years,…

Johnson & Johnson plans $55 billion in US investments over the next four years

Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years,…

Pharma: Johnson & Johnson will über 55 Milliarden Dollar in USA investieren

Der Pharmakonzern will seine Investitionen in den USA ausweiten. Es sollen zusätzliche Produktionsstätten und Forschungsinfrastruktur entstehen.…

J&J plans to invest more than $55 billion in US over next four years

Johnson & Johnson said on Friday it plans to invest more than $55 billion over the next four years to…

JNJs Nipocalimab Gets FDAs Fast Track Tag for Sjogrens Disease

The FDA bestows a Fast Track designation to Johnson & Johnsons nipocalimab for treating moderate-to-severe Sjogrens disease in adults.…

Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific

Todays Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Johnson & Johnson (JNJ) and…

Johnson & Johnson (JNJ) Rises But Trails Market: What Investors Should Know

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $162.84, denoting a +0.02% change from…

Assa Abloy board member resigns to join Johnson Controls By Investing.com

Assa Abloy board member resigns to join Johnson Controls…

Kroger CEO Shake-Up

In this podcast, Motley Fool analysts Nick Sciple and Karl Theil join hosts Ricky Mulvey and Mary Long to discuss: Krogers…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

S&P 500 Index Funds Yield Just 1.3%. Consider Buying These 2 Low-Cost Vanguard ETFs to Generate More Passive Income.

The heaviest weighted components of the S&P 500 are companies like Apple, Microsoft, and Nvidia -- tech leaders that tend…

Cool, Calm, and Collected: 2 Dividend ETFs to Buy During the S&P 500 Sell-Off

A stock market correction occurs when a major index falls 10% off its highs. The S&P 500 (SNPINDEX: ^GSPC) hit…

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…

Johnson & Johnson zieht die Reißleine - Genmab-Aktie bricht ein

Die Zusammenarbeit zwischen dem US-Pharmazie- und Konsumgüterhersteller Johnson & Johnson und dem dänischen Onkologie-Spezialisten Genmab ist vor allem bei der…

2025 March Market Cap Showdown: Andy Cross vs. Matt Argersinger

Its time for another Market Cap Game Show. To catch full episodes of all The Motley Fools free podcasts, check…

Zacks Investment Ideas feature highlights: Coca-Cola, Philip Morris and Johnson & Johnson

Coca-Cola, Philip Morris and Johnson & Johnson are part of the Zacks Investment Ideas article.…

Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson

Gilead Sciences and Johnson & Johnson are part of the Zacks Investment Ideas article.…

3 ETFs to Buy Now for Passive Dividend Income

With volatility spiking and stock market indexes like the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) down on…

Pfizer Vs. Johnson & Johnson: Whos The Better Bargain For Investors

…

Kenvue settles proxy fight with activist Starboard, adding three directors to its board

Starboards Jeff Smith will join the board of the Johnson & Johnson spinoff.…